CERS3
Ceramide synthase 3
Also known as: CERS3_HUMAN, LASS3, MGC27091
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IU89
- Gene
- CERS3
- Ensembl
- ENSG00000154227
- Chromosome
- 15
- Canonical length
- 383 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene is a member of the ceramide synthase family of genes. The ceramide synthase enzymes regulate sphingolipid synthesis by catalyzing the formation of ceramides from sphingoid base and acyl-coA substrates. This family member is involved in the synthesis of ceramides with ultra-long-chain acyl moieties (ULC-Cers), important to the epidermis in its role in creating a protective barrier from the environment. The protein encoded by this gene has also been implicated in modification of the lipid structures required for spermatogenesis. Mutations in this gene have been associated with male fertility defects, and epidermal defects, including ichthyosis. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]
Canonical amino-acid sequenceUniProt
383 residues, UniProt reviewed canonical sequence.
>Q8IU89|CERS3
1 MFWTFKEWFW LERFWLPPTI KWSDLEDHDG LVFVKPSHLY VTIPYAFLLL IIRRVFEKFV
61 ASPLAKSFGI KETVRKVTPN TVLENFFKHS TRQPLQTDIY GLAKKCNLTE RQVERWFRSR
121 RNQERPSRLK KFQEACWRFA FYLMITVAGI AFLYDKPWLY DLWEVWNGYP KQPLLPSQYW
181 YYILEMSFYW SLLFRLGFDV KRKDFLAHII HHLAAISLMS FSWCANYIRS GTLVMIVHDV
241 ADIWLESAKM FSYAGWTQTC NTLFFIFSTI FFISRLIVFP FWILYCTLIL PMYHLEPFFS
301 YIFLNLQLMI LQVLHLYWGY YILKMLNRCI FMKSIQDVRS DDEDYEEEEE EEEEEATKGK
361 EMDCLKNGLR AERHLIPNGQ HGHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CERS3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 6
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 62 nTPM
Expression across tissuesHPA
Tissue
- skin: 62 nTPM
- esophagus: 53 nTPM
- vagina: 29 nTPM
- cervix: 22 nTPM
- testis: 17 nTPM
- tonsil: 15 nTPM
Single-cell type
- esophageal apical cells: 819 nCPM
- esophageal suprabasal cells: 358 nCPM
- suprabasal keratinocytes: 242 nCPM
- esophageal basal cells: 116 nCPM
- epicardial cells: 105 nCPM
- basal keratinocytes: 88 nCPM
Immune cell
- naive CD4 T-cell: 0.6 nTPM
- eosinophil: 0.4 nTPM
- memory CD4 T-cell: 0.1 nTPM
- non-classical monocyte: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
Brain region
- cerebellum: 1 nTPM
- hypothalamus: 0.8 nTPM
- basal ganglia: 0.7 nTPM
- cerebral cortex: 0.6 nTPM
- amygdala: 0.5 nTPM
- hippocampal formation: 0.5 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CERS3.
Disease | AllUniProt
Conditions CERS3 is implicated in, by any mechanism.
- Ichthyosis, congenital, autosomal recessive 9 (ARCI9) MIM:615023
Disease | GeneticClinVar
18 pathogenic / likely-pathogenic of 157 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Autosomal recessive congenital ichthyosis 9
- Abnormality of the skin
- Lamellar ichthyosis
- Ichthyosis
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.63
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.61
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- ceramide biosynthetic process
- cornification
- epidermis development
- keratinocyte differentiation
- sphingolipid biosynthetic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CERS3 as an antibody target. Whether an autoantibody or antibody against CERS3 could matter depends on whether native CERS3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CERS3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CERS3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...